We are monitoring the impact of COVID-19 on APAC Digital Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date March, 2021
ID: 11380
Share on
Share on

APAC Digital Therapeutics Market Size, Share, Trends and Growth Analysis Report – Segmented By Product, Sales Channel, Application and Country (United Kingdom, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands and Rest of Europe) - Industry Forecast (2021 to 2026)

Pulished: March, 2021
ID: 11380
Pages: 100

APAC Digital Therapeutics Market Size (2021 to 2026)

The size of the digital therapeutics market in Asia-Pacific is predicted to worth USD 1308 million by the end of 2026.

The digital therapeutics market in this region is primarily driven by the increasing usage of smartphones & tablets and y-o-y growth in the incidence of chronic diseases. Technological advancements in mobile healthcare in the APAC region and improved drug compliance boost the digital therapeutics market in the Asia Pacific. Furthermore, the demand for PDTx is growing due to their profitability.

Other factors such as easy accessibility, patient comfort, and the potentiality to influence behavioral change propel the market growth. Y-O-Y rise in the aging population suffering from chronic diseases is expected to influence the prescription digital therapeutic market demand worldwide. Government initiatives for better healthcare services in the region and improving healthcare infrastructure encourage market growth. 

However, lack of awareness and access to digital therapeutics programs in emerging countries impede the market growth. The digital therapeutics market's primary concerns are unstable payment models and patient data privacy concerns, which restrain the market growth. Also, resistance from traditional healthcare providers diminishes the market growth. 

Impact of COVID-19 on the Asia-Pacific digital therapeutics market:

The emergence of the outbreak has disrupted the APAC region's healthcare systems as the healthcare responses are focused on strengthening the COVID-19 Infrastructure. The need for the substantial shift to apps and hardware capable of lifestyle enhancement and medical intervention has developed during the COVID-19 pandemic period. 

Covid-19 has positively impacted the digital therapeutics market growth. Due to the pandemic, the awareness among the people has increased about the importance of digital health and the proliferation of mental illness, and the rising rate of drug abuse worldwide is expanding the market during the Covid-19 period. 

Moreover, due to the nationwide lockdown, people are restricted to the home, which led to less physical activity, and unhealthy lifestyles, and mental stress has increased chronic diseases. Therefore, the demand for therapeutics devices and software flourishes across the Asia pacific.  

The research report Asia Pacific digital therapeutics market has been segmented and sub-segmented into the following categories.

By Product:

  • Software
  • Device
  • Others

By Sales Channel:

  • B2C
    • Patients
    • Caregivers
  • B2B
    • Providers
    • Payers
    • Employers
    • Pharmaceutical Companies
    • Other Buyers

By Application:

  • Preventive Applications
    • Prediabetes
    • Obesity
    • Nutrition
    • Lifestyle Management
    • Other Preventive Applications
  • Treatment/Care-related Applications
    • Diabetes
    • CNS Disorders
    • Chronic Respiratory Disorders
    • Musculoskeletal Disorders
    • Cardiovascular Diseases
    • Smoking Cessation
    • Medication Adherence
    • Gastrointestinal Disorders
    • Substance Use & Addiction Management
    • Rehabilitation & Patient Care
    • Other Treatment/Care-related Applications

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific market is estimated to grow at a progressive rate during the forecast period. In the APAC, the Chinese market is expected to register a healthy growth rate between 2021 to 2026. The Indian market is more likely to grow at a significant rate during the forecast period.  Growth in the number of hospital apps and the prevalence of chronic diseases are boosting the Indian market.

The digital therapeutics market in Japan and Australia are likely to expand at a robust rate during the forecast period and is driven by the growing usage of tablets and smartphones.

LEADING COMPANIES IN THE MARKET:

Companies like Fitbit, Inc. (Twine Health, Inc.), Medtronic Plc., Novartis International AG (Pear Therapeutics, Inc.), Resmed, Inc. (Propeller Health), Voluntis, Inc., Ada Health GmbH, Cognifit ltd, Caterna Vision GmbH, Sonormed GmbH, and Kaia Health are playing a leading role in the APAC digital therapeutics market.

  1. Introduction
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year and Forecast Periods
    4. General Study Assumptions
  2. Research Methodology
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Overview
    1. Executive Summary
    2. Key Inferences
    3. New Developments
  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
    1. Market Drivers
    2. Market Restraints
    3. Key Challenges
    4. Current Opportunities in the Market
  5. Market Segmentation
    1. By Product
      1. Software
      2. Device
      3. Others
      4. Y-o-Y Growth Analysis, By Product
      5. Market Attractiveness Analysis, By Product
      6. Market Share Analysis, By Product
    2. By Sales Channel
      1. B2C
        1. Patients
        2. Caregivers
      2. B2B
        1. Providers
        2. Payers
        3. Employers
        4. Pharmaceutical Companies
        5. Other Buyers
      3. Y-o-Y Growth Analysis, By Sales Channel
      4. Market Attractiveness Analysis, By Sales Channel
      5. Market Share Analysis, By Sales Channel
    3. By Application
      1. Preventive Applications
        1. Prediabetes
        2. Obesity
        3. Nutrition
        4. Lifestyle Management
        5. Other Preventive Applications
      2. Treatment/Care-related Applications
        1. Diabetes
        2. CNS Disorders
        3. Chronic Respiratory Disorders
        4. Musculoskeletal Disorders
        5. Cardiovascular Diseases
        6. Smoking Cessation
        7. Medication Adherence
        8. Gastrointestinal Disorders
        9. Substance Use & Addiction Management
        10. Rehabilitation & Patient Care
        11. Other Treatment/Care-related Applications
      3. Y-o-Y Growth Analysis, By Application
      4. Market Attractiveness Analysis, By Application
      5. Market Share Analysis, By Application
  6. Geographical Analysis
    1. Introduction    
      1. Regional Trends   
      2. Impact Analysis    
      3. Y-o-Y Growth Analysis        
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      4. Market Attractiveness Analysis      
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
      5.      Market Share Analysis   
        1. By Geographical Area
        2. By Product
        3. By Technology
        4. By Application
        5. By End-User
    2. APAC
      1. Introduction
      2. India
      3. China
      4. Japan
      5. Australia
      6. South Korea
      7. Rest of APAC
  7. Strategic Analysis
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. Threat of New Entrants
      4. Threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  8. Market Leaders' Analysis
    1. 2Morrow, Inc.,
      1. Overview
      2. Product Analysis
      3. Strategic Evaluation and Operations
      4. Financial analysis
      5. Legal issues
      6. Recent Developments
      7. SWOT analysis
      8. Analyst View
    2. Pear Therapeutics, Inc.
    3. Fitbit, Inc. (Twine Health, Inc.)
    4. Proteus Digital Health, Inc.
    5. Livongo Health, Inc.
    6. Resmed, Inc. (Propeller Health)
    7. Medtronic Plc.
    8. Voluntis, Inc.
    9. Omada Health, Inc.
    10. Welldoc, Inc.
  9. Competitive Landscape
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  10. Market Outlook and Investment Opportunities
  11. Appendix
    1. List of Tables
    2. List of Figures  
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of product type along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.
  • Asia Pacific Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • Asia Pacific Software Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Device Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • Asia Pacific B2C Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific B2B Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • Asia Pacific Preventive Application Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Treatment/Care-related Applications Market, By Region, From 2021 to 2026 (USD Million)
  • Japan Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • Japan Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • Japan Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • China Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • China Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • China Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • India Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • India Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • India Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • Australia Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • Australia Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • Australia Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • South Korea Digital Therapeutics Market, By Product, From 2021 to 2026 (USD Million)
  • South Korea Digital Therapeutics Market, By Sales Channels, From 2021 to 2026 (USD Million)
  • South Korea Digital Therapeutics Market, By Application, From 2021 to 2026 (USD Million)
  • Asia Pacific Blood Glucose Monitoring Market, By B2B, From 2021 to 2026 (USD Million)
  • Asia Pacific Providers Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Payers Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Employers Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Pharmaceutical Companies Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Other Buyers Market, By Region, From 2021 to 2026 (USD Million)
  • Japan Blood Glucose Monitoring Market, By B2B, From 2021 to 2026 (USD Million)
  • China Blood Glucose Monitoring Market, By B2B, From 2021 to 2026 (USD Million)
  • India Blood Glucose Monitoring Market, By B2B, From 2021 to 2026 (USD Million)
  • Australia Blood Glucose Monitoring Market, By B2B, From 2021 to 2026 (USD Million)
  • Asia Pacific Blood Glucose Monitoring Market, By B2C, From 2021 to 2026 (USD Million)
  • Asia Pacific Patients Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Caregivers Market, By Region, From 2021 to 2026 (USD Million)
  • Japan Blood Glucose Monitoring Market, By B2C, From 2021 to 2026 (USD Million)
  • China Blood Glucose Monitoring Market, By B2C, From 2021 to 2026 (USD Million)
  • India Blood Glucose Monitoring Market, By B2C, From 2021 to 2026 (USD Million)
  • Australia Blood Glucose Monitoring Market, By B2C, From 2021 to 2026 (USD Million)
  • Asia Pacific Blood Glucose Monitoring Market, By Preventive Applications, From 2021 to 2026 (USD Million)
  • Asia Pacific Prediabetes Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Obesity Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Nutrition Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Lifestyle Management Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Other Preventive Applications Market, By Region, From 2021 to 2026 (USD Million)
  • Japan Blood Glucose Monitoring Market, By Preventive Applications, From 2021 to 2026 (USD Million)
  • China Blood Glucose Monitoring Market, By Preventive Applications, From 2021 to 2026 (USD Million)
  • India Blood Glucose Monitoring Market, By Preventive Applications, From 2021 to 2026 (USD Million)
  • Australia Blood Glucose Monitoring Market, By Preventive Applications, From 2021 to 2026 (USD Million)
  • Asia Pacific Blood Glucose Monitoring Market, By Treatment/Care-related Application, From 2021 to 2026 (USD Million)
  • Asia Pacific Diabetes Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific CND disorders Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Chronic Respiratory Disorders Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Musculoskeletal Disorders Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Cardiovascular Diseases Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Smoking Cessation Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Medication Adherence Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Gastrointestinal disorders Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Substance use & Addiction Management Market, By Region, From 2021 to 2026 (USD Million)
  • Asia Pacific Rehabilitation & Patient Care Market, By Region, From 2021 to 2026 (USD Million)
  • Japan Blood Glucose Monitoring Market, By Treatment/Care-related Application, From 2021 to 2026 (USD Million)
  • China Blood Glucose Monitoring Market, By Treatment/Care-related Application, From 2021 to 2026 (USD Million)
  • India Blood Glucose Monitoring Market, By Treatment/Care-related Application, From 2021 to 2026 (USD Million)
  • Australia Blood Glucose Monitoring Market, By Treatment/Care-related Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample